BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27349764)

  • 1. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
    Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Useful Parameters for Distinguishing Subcutaneous Panniculitis-like T-Cell Lymphoma From Lupus Erythematosus Panniculitis.
    LeBlanc RE; Tavallaee M; Kim YH; Kim J
    Am J Surg Pathol; 2016 Jun; 40(6):745-54. PubMed ID: 26796503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
    Carson KR; Horwitz SM; Pinter-Brown LC; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta MA; Shustov AR; Advani RH; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
    Cancer; 2017 Apr; 123(7):1174-1183. PubMed ID: 27911989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan.
    Kobayashi R; Yamato K; Tanaka F; Takashima Y; Inada H; Kikuchi A; Kumagai MA; Sunami S; Nakagawa A; Fukano R; Fujita N; Mitsui T; Tsurusawa M; Mori T;
    Pediatr Blood Cancer; 2010 Feb; 54(2):212-5. PubMed ID: 19856396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
    Tolkachjov SN; Weenig RH; Comfere NI
    J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy Plus Radiotherapy
    Chen Z; Huang H; Li X; Fang X; Wang Z; Hong H; Zhang Z; Cai Q; Li Z; Chen M; Yao Y; Pan F; Chen L; Lin T
    Front Oncol; 2021; 11():607145. PubMed ID: 33680962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).
    Julamanee J; Kayasut K; Lekhakula A
    J Med Assoc Thai; 2015 Oct; 98(10):950-6. PubMed ID: 26638586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.
    López-Lerma I; Peñate Y; Gallardo F; Martí RM; Mitxelena J; Bielsa I; Velasco-Tamariz V; Yanguas-Bayona JI; Sánchez-Sambucety P; García-Patos V; Ortiz-Romero PL; Pujol RM; Estrach T
    J Am Acad Dermatol; 2018 Nov; 79(5):892-898. PubMed ID: 30126736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy.
    Michonneau D; Petrella T; Ortonne N; Ingen-Housz-Oro S; Franck N; Barete S; Battistella M; Beylot-Barry M; Vergier B; Maynadié M; Bodemer C; Hermine O; Bagot M; Brousse N; Fraitag S
    Acta Derm Venereol; 2017 Mar; 97(3):358-364. PubMed ID: 27722764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
    Adams SV; Newcomb PA; Shustov AR
    J Clin Oncol; 2016 Mar; 34(9):963-71. PubMed ID: 26962200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
    Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
    Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.
    Fuji S; Kida S; Nakata K; Morishima T; Miyashiro I; Ishikawa J
    Ann Hematol; 2021 Jan; 100(1):157-165. PubMed ID: 33089366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
    Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
    Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
    Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics and survival of peripheral T-cell lymphoma-not otherwise specified: a report of 57 cases].
    Chen X; Dong DF; Wu YY; Huang HY; Liang J; Li EX
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):916-9. PubMed ID: 20193331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.